In the patients with dementia, 20-26 indicates mild dementia, 10-19 moderate dementia, and below 10 severe dementia.
NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia.
In addition, a method for distinguishing between AD and non-AD dementia is disclosed.
Disclosed is a therapeutic agent for dementia and a method for treatment of dementia.
The present invention is directed to a method for differentially diagnosing dementia or the risk of dementia in a patient.
The invention also relates to a method of preventing and/or treating dementia including senile dementia, that involves the use of this combination of drugs.
Cysteine protease inhibitors are effective for treating dementia, Alzheimer's disease and vascular dementia.
Disclosed is a transdermal patch for treatment of degenerative neurological disorders like dementia or Alzheimer type dementia.
A method for the cognitive assessment of adult patients with severe dementia.
European Collaboration on Dementia
The composition contains two or more types of antidementia agents.